Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial

TerminatedOBSERVATIONAL
Enrollment

937

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

March 31, 2023

Conditions
Trisomy 13Trisomy 18Trisomy 21Aneuploidy
Interventions
PROCEDURE

Blood Draw

Blood will be drawn from the mother and father

Trial Locations (29)

10016

New York University, New York

10029

The Mount Sinai Hospital, New York

10032

Columbia University, New York

10128

Carnegie Imaging for Women, New York

10467

Montefiore Medical Center, New York

11215

NY Methodist Hospital, Brooklyn

11501

Madonna Perinatal, Mineola

18103

Lehigh Valley Hospital, Allentown

27599

University of North Carolina, Chapel Hill

28232

Carolinas Medical Center, Charlotte

29203

University of South Carolina, Columbia

33136

University of Miami, Miami

35233

University of Alabama, Birmingham

46207

Indiana University, Indianapolis

53715

University of Wisconsin, Madison

60521

Adventist Hinsdale Hospital, Hinsdale

77555

University of Texas Medical Branch, Galveston

90048

Cedars-Sinai Medical Center, Los Angeles

94110

California Pacific Medical Center, San Francisco

94305

Stanford University, Stanford

97239

Oregon Health and Science University, Portland

06510

Yale University, New Haven

02111

Massachusetts General Hospital, Boston

Tufts Medical Center, Boston

Unknown

Mt Sinai Hospital, Toronto

Royal College of Surgeons in Ireland, Dublin

University of Perugia, Perugia

Hamchoon Women's Clinic, Seoul

Institut Universitari Dexeus, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Columbia University

OTHER

collaborator

George Washington University

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Natera, Inc.

INDUSTRY

NCT01545674 - Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial | Biotech Hunter | Biotech Hunter